Victim says eyes were injured by Alcon Laser System
Dallas, TX (PRWEB via PR Web Direct)
February 4, 2005 -- A Lubbock County, Texas woman is suing the Fort Worth maker
of a laser system used by doctors to perform LASIK eye surgery. According to the
lawsuit, Sandra Brown v. Alcon Manufacturing, L.T.D. and Alcon Laboratories,
Inc., the LADARVision laser is defective (Case #236-209603-05 District Court
Tarrant County Texas 236th Judicial District). The lawsuit accuses Alcon of
ignoring warnings that may have prevented additional injuries.
A surgeon performed LASIK surgery on Dr. Brown, a fellow ophthalmologist, in
April 2001, using the LADARVision laser. During the surgery, the laser performed
erratically and removed too little tissue in an asymmetrical pattern from Dr.
Brown’s eyes. As a result, she sustained permanent damage to her eyes
resulting in limited vision. Unfortunately for Dr. Brown, at this time, her
vision cannot be repaired by medical or surgical interventions.
“I specifically waited for the LADARVision laser machine before having my
surgery, and the wait cost me my vision,” says Dr. Brown. “I now have to
live with damaged vision because of a defect in Alcon's laser. When I started
looking into my problem, I realized that I was not alone and many other people
have likewise been hurt by this same problem.”
While horror stories associated with laser vision correction are not new, recent
disturbing news about the Alcon LADARVision laser may cause victims to consider
whether harm to their eyes was caused by the laser and not doctors and medical
staff.
“In the past, poor surgeries were usually blamed on the surgeon,” says
attorney Joel Fineberg, who represents Dr. Brown. “There is now mounting
evidence that the Alcon LADARVision laser is at the heart of many of these
problems.”
Surgeons throughout the country are questioning the effectiveness of the laser.
In addition, an article authored by an Alcon consultant in the April 2003 issue
of Opthalmology, reveals that patients treated with the LADARVision laser are
twice as likely to need follow-up surgery. According to an investigative report
in the London Times the rate of required retreatment might be even higher.
“Patients go in expecting to come out with clearer vision, and many times they
come out with permanent damage,” says Mr. Fineberg. “What we have here is a
company that has decided to ignore serious concerns, raised by a physician,
about the safety of their product.”
To speak with Joel Fineberg about problems associated with Alcon’s LADARVision,
contact Joel Fineberg at (214)219-8828 or Mike Androvett at (800)559-4534.